Semma Therapeutics' Series A Round

Semma Therapeutics raised a round of funding on March 24, 2015.

Semma Therapeutics is a biopharmaceutical company developing Stem Cell-derived Islet therapy for type 1 diabetes.…

Articles about Semma Therapeutics' Series A Round: